Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
| Parent link: | Pharmaceutics.— .— Basel: MDPI AG Vol. 15, iss. 7.— 2023.— Article number 1802, 20 p. |
|---|---|
| Outros Autores: | Matveevskaya V. V. Vladislava Vadimovna, Pavlov D. I. Dmitry Igorevich, Kovrizhina A. R. Anastasia Ruslanovna, Sukhikh T. S, Taisiya Sergeevna, Sadykov E. Kh. Evgeny Khasanovich, Dorovatovskii P. V. Pavel Vladimirovich, Lazarenko V. A. Vladimir Aleksandrovich, Khlebnikov A. I. Andrey Ivanovich, Potapov A. S. Andrey Sergeevich |
| Resumo: | Title screen 11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-) in these compounds was so far unknown. In this contribution, we report the results of the determination of the double bond configuration in the solid state by single crystal X-ray diffraction and in solution by 1D and 2D NMR techniques and DFT calculations. It was found that both in the solid state and in solution, IQ-1 adopts the E-configuration stabilized by intermolecular hydrogen bonds, in contrast to previously assumed Z-configuration that could be stabilized only by an intramolecular hydrogen bond Текстовый файл |
| Idioma: | inglês |
| Publicado em: |
2023
|
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.3390/pharmaceutics15071802 |
| Formato: | Recurso Eletrônico Capítulo de Livro |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682051 |
Registros relacionados
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Publicado em: (2020)
Publicado em: (2020)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Publicado em: (2018)
Publicado em: (2018)
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Publicado em: (2023)
Publicado em: (2023)
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Publicado em: (2021)
Publicado em: (2021)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Publicado em: (2022)
Publicado em: (2022)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Publicado em: (2025)
Publicado em: (2025)
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential; Biomolecules; Vol. 11, iss. 6
Publicado em: (2021)
Publicado em: (2021)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Publicado em: (2024)
Publicado em: (2024)
The Effect of Tryptanthrin and Its Oxime on the Blood–Brain Barrier Permeability in Rats with Cerebral Infarction; Bulletin of Experimental Biology and Medicine; Vol. 179, iss. 2
Publicado em: (2025)
Publicado em: (2025)
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Publicado em: (2023)
Publicado em: (2023)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Publicado em: (2023)
Publicado em: (2023)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Publicado em: (2023)
Publicado em: (2023)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Publicado em: (2019)
Publicado em: (2019)
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Publicado em: (2019)
Publicado em: (2019)
The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
Publicado em: (2023)
Publicado em: (2023)
Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Publicado em: (2020)
Publicado em: (2020)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Publicado em: (2023)
Publicado em: (2023)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Publicado em: (2018)
Publicado em: (2018)
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Publicado em: (2020)
Publicado em: (2020)
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Publicado em: (2019)
Publicado em: (2019)
Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 177, iss. 3
Publicado em: (2024)
Publicado em: (2024)
Synthesis and biological evaluation of alkali metal salts of tryptanthrin-6-oxime; 53rd International Union of Pure & Applied Chemistry General Assembly (IUPAC 2025) and 50th World Chemistry Congress (50WCC)
por: Kovrizhina A. R. Anastasia Ruslanovna
Publicado em: (2025)
por: Kovrizhina A. R. Anastasia Ruslanovna
Publicado em: (2025)
A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia–reperfusion injury in mice; Neuroscience Letters; Vol. 618
Publicado em: (2016)
Publicado em: (2016)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Publicado em: (2024)
Publicado em: (2024)
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Publicado em: (2025)
Publicado em: (2025)
Methods for the Preparation of New 11H-Indeno[1,2-b]Quinoxalin-11-One Oxime Analogs as Promising JNK Inhibitors; International Conference on Physical Organic Chemistry (ICPOC 24)
Publicado em: (2018)
Publicado em: (2018)
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25; European Journal of Medicinal Chemistry; Vol. 183
Publicado em: (2019)
Publicado em: (2019)
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Publicado em: (2020)
Publicado em: (2020)
Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
Publicado em: (2020)
Publicado em: (2020)
Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity; Molecules; Vol. 30, iss. 14
Publicado em: (2025)
Publicado em: (2025)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Publicado em: (2022)
Publicado em: (2022)
Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Publicado em: (2023)
Publicado em: (2023)
Rotational Barriers in N-Benzhydrylformamides: An NMR and DFT Study; Molecules; Vol. 28, iss. 2
Publicado em: (2023)
Publicado em: (2023)
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Publicado em: (2018)
Publicado em: (2018)
Getting benzhydrylamine by reductionreaction of benzophenone oxime; Химия и химическая технология в XXI веке; Т. 2
por: Danilenko N. V. Nadezhda Viktorovna
Publicado em: (2014)
por: Danilenko N. V. Nadezhda Viktorovna
Publicado em: (2014)
Preparation de formamide de la benzophenone oxime et les O-derives; Перспективы развития фундаментальных наук
por: Danilenko N. V. Nadezhda Viktorovna
Publicado em: (2014)
por: Danilenko N. V. Nadezhda Viktorovna
Publicado em: (2014)
Kinase Inhibitors Methods and Protocols /
Publicado em: (2012)
Publicado em: (2012)
Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia; Cells; Vol. 9, iss. 8
Publicado em: (2020)
Publicado em: (2020)
The Role of Steel Surface Topography in the Performance of Nanostructured Corrosion Inhibitors; Transactions of the Indian Institute of Metals; Vol. 78, iss. 11
por: Dubinina O. V. Oksana Valerievna
Publicado em: (2025)
por: Dubinina O. V. Oksana Valerievna
Publicado em: (2025)
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors; Bioorganic & Medicinal Chemistry; Vol. 29, iss. 1
Publicado em: (2021)
Publicado em: (2021)
Registros relacionados
-
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Publicado em: (2020) -
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Publicado em: (2018) -
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Publicado em: (2023) -
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Publicado em: (2021) -
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Publicado em: (2022)